| Health / Medical Topics |
Cancer Stemness Inhibitor BBI608
An orally available cancer cell stemness inhibitor with potential antineoplastic activity. Even though the exact target has yet to be fully elucidated, BBI608 appears to target and inhibit multiple pathways involved in cancer cell stemness. This may ultimately inhibit cancer stemness cell (CSC) growth as well as heterogeneous cancer cell growth. CSCs, self-replicating cells that are able to differentiate into heterogeneous cancer cells, appear to be responsible for the malignant growth, recurrence and resistance to conventional chemotherapies. (NCI Thesaurus)
YOU MAY ALSO LIKE
A malignant cell which may derive from mutations in normal stem cells. Cancer stem cells proliferate and give rise to other malignant…
The use of any device, marker, or other means for the purpose of detecting the presence of a tumor, usually before there…
Systematic investigation into the causes, basic science, detection, and treatment of cancer.
Model systems that predict the occurrence of cancer in a population based on several parameters. These parameters serve as indicators of the…
The probability that exposure to some agent or substance will adversely transform cells to replicate and form a malignant tumor. (EPA Terminology…
Ten major, non-profit managed care organizations that are members of the HMO Research Network will participate in the project, known as the…
